Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home Lifestyle Health and Longevity

Stone Ridge’s Predictable Cash Flows: Longevity Income ETFs

by Team Lumida
July 4, 2024
in Health and Longevity
Reading Time: 3 mins read
A A
0
Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

  1. Stone Ridge introduces 32 Longevity Income ETFs targeting predictable monthly cash flows for retirees.
  2. Funds invest in US Treasuries and government money markets, with options for inflation protection.
  3. Competitors like BlackRock and T Rowe Price also eye post-retirement income market.

What Happened?

Stone Ridge has filed to launch 32 Longevity Income ETFs, specifically designed to provide regular monthly income for elderly investors. These ETFs target investors who will turn 100 between 2048 and 2063, generating income starting 20 years before that. The funds invest initially in US Treasuries and government money market funds.

A companion suite, the Inflation-Protected Longevity Income ETFs, will invest in Treasury Inflation-Protected Securities. Each ETF aims to generate monthly distributions of $0.0833 per share, totaling $1 per share annually.

Why It Matters?

The introduction of these ETFs addresses a significant gap in the market. Many products focus on asset accumulation rather than converting those assets into predictable cash flows. Stone Ridge’s offering provides a solution for retirees seeking steady income, crucial for financial planning.

The funds’ design, with options for term-income distributions or converting shares into a closed-end fund, offers flexibility. Additionally, the involvement of a market leader in income annuities for actuarial services ensures robust financial planning.

What’s Next?

As competition intensifies among fund firms for post-retirement assets, Stone Ridge’s ETFs could set a new standard. With fees yet to be disclosed, investors should watch for cost details. The funds liquidate in December of the target year, ensuring distributed assets by that time.

Given the market’s response to the Secure Act of 2019, which encouraged guaranteed-income options, expect similar offerings from competitors like BlackRock, Capital Group, and T Rowe Price. Investors should monitor how these ETFs perform compared to traditional retirement income products.

Source: Financial Times
Tags: ETFLongevity Income ETFsRetirement incomeStone Ridge
Previous Post

Bitcoin Crashes Below $59K: $230M in Liquidations Rock Crypto Market

Next Post

Goldman Sachs vs. Fed: $6 Billion Stress Test Showdown

Recommended For You

Fiber Is the Longevity Hack Most Diets Still Miss

by Team Lumida
18 hours ago
green leaves on blue plastic bowl

Key takeaways Powered by lumidawealth.com Higher fiber intake is associated with lower mortality and chronic disease risk. Fiber improves gut microbiome health, which affects metabolism, immunity, and inflammation. Most...

Read more

Mobile Screens Are the Modern Health Risk Hiding in Plain Sight

by Team Lumida
4 days ago
person holding blue and white box

Key takeaways Powered by lumidawealth.com High mobile screen time is linked to poorer sleep quality, largely due to blue light exposure and late-night device use. Digital overuse contributes to...

Read more

Protein Timing Is the Longevity Multiplier

by Team Lumida
7 days ago
a container of protein powder next to a spoon

Key takeaways Most adults under-consume protein at breakfast and overconsume it at dinner. Muscle protein synthesis is optimized when ~25–40g of protein is consumed per meal. Even distribution...

Read more

Rare Glioblastoma Survivors Are Rewriting the Playbook—and Pointing to New Therapies

by Team Lumida
2 weeks ago
Rare Glioblastoma Survivors Are Rewriting the Playbook—and Pointing to New Therapies

Key takeaways Powered by lumidawealth.com Researchers are rethinking glioblastoma as a distributed, neuron-connected network—not just a tumor mass—helping explain why standard therapies often fail. New evidence shows tumor cells...

Read more

VO₂ Max Is the Longevity Multiplier

by Team Lumida
2 weeks ago
silhouette photography of woman doing yoga

Key takeaways Powered by lumidawealth.com Higher VO₂ max is strongly associated with lower all-cause mortality. Moving from low to moderate fitness can cut mortality risk dramatically. Cardiorespiratory fitness often...

Read more

The Hidden Cost of ‘Sleep Shame’: How Social Pressure Is Undermining Rest—and Performance

by Team Lumida
2 weeks ago
woman sleeping on bed under blankets

Key takeaways Powered by lumidawealth.com “Sleep shame” is emerging as a social and psychological stressor, affecting both early birds and night owls. Cultural norms that equate productivity with early...

Read more

Green Veggies Are the Longevity Hack You Need to Eat Every Day

by Team Lumida
3 weeks ago
a close up of a bunch of green plants

Key takeaways Powered by lumidawealth.com Green vegetables like spinach, kale, and broccoli are rich in antioxidants, fiber, and essential vitamins, which can boost health and longevity. A plant-based diet...

Read more

VO₂ Max Is the Longevity Fitness Metric Most People Ignore

by Team Lumida
3 weeks ago
a woman wearing a mask and running in a field

Key Takeaways Powered by lumidawealth.com VO₂ max is one of the strongest measurable predictors of longevity and all-cause mortality. Higher VO₂ max reflects better heart, lung, and mitochondrial function...

Read more

Melatonin Is the Sleep Timing Hack — Not a Knockout Pill

by Team Lumida
3 weeks ago
Melatonin Is the Sleep Timing Hack — Not a Knockout Pill

Key Takeaways Powered by lumidawealth.com Melatonin works best as a circadian “time cue” (sleep schedule/jet lag), not as a general sedative for chronic insomnia. Timing matters more than dose:...

Read more

Sleep Regularity Is the Longevity Hack

by Team Lumida
3 weeks ago
woman sleeping on bed under blankets

Key Takeaways: Powered by lumidawealth.com Sleep regularity often matters more than total sleep duration for long-term health outcomes. Irregular sleep schedules are linked to higher risks of metabolic disease,...

Read more
Next Post
Goldman’s Big Bet on Wealth Lending: Doubling Down on the Ultra-Rich

Goldman Sachs vs. Fed: $6 Billion Stress Test Showdown

Fed Minutes Reveal Reluctance to Cut Rates Amid Inflation Worries

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

Nvidia Defies US Controls: $12 Billion AI Chip Sales in China

Nvidia Predicts Cooler Growth After Sales Record

August 28, 2025
a pile of gold bitcoins sitting on top of a table

Bitcoin Crashes to $62K: What’s Behind the $150M Liquidation?

June 24, 2024
S&P 500’s Big Earnings Test: Will Tech Slowdown Derail Gains?

US Futures Dip: What’s Next After S&P 500’s Record Close?

September 25, 2024

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips AI demand Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC Semiconductor stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018